Intradermal injection Market Forecast to 2028

Report Code : TIPRE00019998 | Region : Global | Industry : Medical Device | Published Date : 22/Aug/2022
Intradermal injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Method (Normal Sized Needles, Short Needle {Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices}, and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors}), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others)

The intradermal injection market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.

The report highlights trends prevailing in the market and factors driving the market growth. The intradermal injection market growth is attributed to the increasing intradermal vaccination, increasing incidence of various diseases, and rising acceptance of aesthetic procedures. Additionally, stratageic developments by manufacturers are likely to emerge as a significant trend in the market during the forecast period. However, the risks, complications, and dosing limitations associated with Intradermal Injections hamper the growth of the intradermal injection market.

Most of the developing and developed countries are currently considering the healthcare sector as one of the essential segments, which resulted in the exponential increase in healthcare expenditure with the aim of providing better infrastructure and medical facilities. For fulfilling the rising global demand, various pharmaceutical giants are working to develop ideal drugs and devices, and intradermal injections are emerging as one of the potential devices used for the treatment, diagnosis, vaccination, and cosmetic procedures. Rising acceptance of intradermal vaccination is believed to act as major driver for the global intradermal injection market as it has several advantages over the conventional method of vaccination. Intradermal vaccination helps in reducing the potential dose of antigens, improves the immune response generated by the vaccine and decrease the anxiety associated with the vaccination. By developing intradermal injection, a large population can be vaccinated with comparatively lesser production of the vaccine while this method is also able to vaccinate the difficult group of population with comorbidities as chances of adverse events is low as compared to conventional vaccination. Recently, several intradermal COVID19 vaccines, hepatitis A vaccine, hepatitis B vaccine, Influenza vaccines, polio vaccine measles vaccine, Rabies vaccine, tetanus vaccine, yellow fever vaccine, diphtheria-tetanus-pertussis vaccine etc. shows improvement in the overall response rate and hence several leading pharmaceutical and biotechnological companies are currently working on the development of intradermal injections of the new as well as commercially available vaccines. In 2020, Sanofi received the FDA approval for its intradermal vaccine of Influenza names Fluzone, which is rapidly overtaking the influenza vaccine market and replacing the congenital treatments for these diseases.

Further, more than one-third of the global population has a risk of developing tuberculosis, and an intense increase in the number of tuberculosis skin test procedures has been observed during the past few years. Intradermal tuberculin syringes are used for diagnosing tuberculosis, and several leading manufacturers of drug delivery devices are currently developing these tuberculin syringes. Along with this, the prevalence of allergies has increased several times during the past decade, mainly due to the rise in awareness among the population about several allergy-related conditions. The intradermal injections are used as an ideal device for conducting sensitivity tests for several allergens.

In addition to this, the local aesthetic procedures are also increasing rapidly, and the number of nonsurgical cosmetic procedures has increased by 51.4% from 2011 to 2017 as per the estimates of ISAPS. Along with this, many new intradermal vaccinations are believed to get approval as intradermal vaccination is able to produce better response along with reduction in the required dose and adverse events. . Along with this, several studies concluded that the intradermal injection could improve the uptake of various cancers and immunological drugs while it can also be used to deliver the gene therapies. Further, continuously increasing cases of COVID19 is also indicating towards the future potential of this segment as various intradermal preparations are under investigation and about to get approved in near future. As the global population is increasing continuously, the number of cases will also increase in near future, which ultimately increases the demand of intradermal injection. Further, the novel intradermal injection devices such as Tropis ID of Pharmajet shows prominent results in delivering various drugs for targeting a wide range of diseases and expands the therapeutic area of the intradermal products.

Besides the benefits of intradermal injection, several drawbacks are also associated with these drug delivery devices including injection site reactions and dosing limitations, which are acting as major restraints for the intradermal injection market. It is observed that skin discoloration, swelling, redness, itching and irritation occurs at the site of injection after the intradermal delivery of active ingredient. For overcoming the challenges related to the injection site infections, the researchers are working to identify ideal site for injecting the drug depending upon the nature of drug and required action.

During the past few years, intradermal injections associated procedures and devices have undergone continuous innovations, and several novel technologies are incorporated in this segment for the advancement of this sector. The vaccination and diagnosis rates related to several complications have increased exponentially during the last decade, ultimately increasing the acceptance of intradermal injections.

Several organic and inorganic strategies are adopted by companies in the intradermal injection market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the intradermal injection market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and augment their geographic presence, thereby contributing to the overall growth of intradermal injection market. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few of the noteworthy developments by key players in the intradermal injection market are listed below.

• In November 2021, NanoPass Technologies and Aesthetic Management Partners entered into an agreement to initiate the commercialization of NanoPass’s MicronJet 600 intradermal delivery device in the US.

• In August 2021, PharmaJet and Zydus Cadila received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D, the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is solely administered utilizing the PharmaJet Tropis Needle-free Injection System.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness are among the primary and secondary sources referred while preparing the report on the intradermal injection market.

The List of Companies - Intradermal injection Market

1. BD

2. West Pharmaceuticals Services

3. Terumo Corporation

4. Nanopass

5. Pharmajet

6. Idevax

7. Ensung Global

8. Crossject

9. Cardinal Health

10. Hindustan Syringes and Medical Devices

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Intradermal Injections Market – By Method

1.3.2 Global Intradermal Injections Market – By Application

1.3.3 Global Intradermal Injections Market – By End User

1.3.4 Global Intradermal Injections Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Intradermal Injections Market Landscape

4.1 Overview

4.2 PEST ANALYSIS

4.2.1 North America - PEST Analysis

4.2.2 Europe - PEST Analysis

4.2.3 Asia-Pacific - PEST Analysis

4.2.4 Middle East and Africa - PEST Analysis

4.2.5 South and Central America - PEST Analysis

4.3 EXPERT OPINIONS

5. Intradermal Injections Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Increasing Intradermal Vaccination

5.1.2 Increasing Incidences of diseases

5.1.3 Rising Acceptance of Aesthetic Procedures

5.2 Key Market Restraints

5.2.1 Risks, Complications, and Dosing Limitations Associated with Intradermal Injections

5.3 Key Market Opportunities

5.3.1 Significant Growth Opportunities in Developed as Well As Developing Countries

5.4 Future Trends

5.4.1 Strategic Developments by Manufacturers

5.5 Impact Analysis of Drivers And Restraints

6. Intradermal Injections Market– Global Analysis

6.1 Global Intradermal Injections Market Revenue Forecast and Analysis

6.2 Global Intradermal Injections Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Global Intradermal Injections Market Revenue And Forecasts To 2028– By Method

7.1 Overview

7.2 Global Intradermal Injections Market, By Method, 2021 & 2028 (%)

7.3 Normal-Sized Needles (MANTOUX)

7.3.1 Overview

7.3.2 Normal-Sized Needles (Mantoux): Intradermal Injection Market Revenue and Forecasts To 2028 (US$ MN)

7.4 Short Needles

7.4.1 Overview

7.4.2 Short Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.3 Intradermal Microinjection

7.4.3.1 Overview

7.4.3.2 Intradermal Microinjection: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.4 Microneedle Arrays

7.4.4.1 Overview

7.4.4.2 Microneedle Arrays: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.4.5 Tattoo Devices

7.4.5.1 Overview

7.4.5.2 Tattoo Devices: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5 Without Needles

7.5.1 Overview

7.5.2 Without Needles: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.3 Intradermal Liquid Jet Injectors

7.5.3.1 Overview

7.5.3.2 Intradermal Liquid Jet Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

7.5.4 Ballistic Intradermal Injectors

7.5.4.1 Overview

7.5.4.2 Ballistic Intradermal Injectors: Intradermal Injection Market Revenue and Forecast to 2028 (US$ Million)

8. Intradermal Injections Market Revenue and Forecasts To 2028 – Application

8.1 Overview

8.2 Global Intradermal Injections Market Share by Application - 2021 & 2028 (%)

8.3 Tuberculin Skin Testing

8.3.1 Overview

8.3.2 Tuberculin Skin Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4 Allergy Testing

8.4.1 Overview

8.4.2 Allergy Testing Market Revenue and Forecast to 2028 (US$ Million)

8.5 Local Aesthetics

8.5.1 Overview

8.5.2 Local Aesthetics Market Revenue and Forecast to 2028 (US$ Million)

8.6 OTHERS

8.6.1 Overview

8.6.2 Others Market Forecast and Analysis

9. Intradermal Injections Market Analysis - End User

9.1 Overview

9.2 Global Intradermal Injections Market, By End User, 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

9.6 OTHERS

9.6.1 Overview

9.6.2 Others: Intradermal Injections Market Revenue and Forecast to 2028 (US$ Million)

10. Intradermal Injections Market Revenue And Forecasts To 2028 – Geographical Analysis

10.1 North America: Intradermal Injections Market

10.1.1 Overview

10.1.2 North America: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3 North America: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.3.1 North America: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.3.2 North America: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.4 North America: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.5 North America: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

10.1.6 North America: Intradermal Injections Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1 Overview

10.1.6.1.2 US: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3 US: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.6.1.3.1 US: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.6.1.3.2 US: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.6.1.4 US: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.6.1.5 US: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

10.1.6.2 Canada: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1 Overview

10.1.6.2.2 Canada: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3 Canada: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.6.2.3.1 Canada: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.6.2.3.2 Canada: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.6.2.4 Canada: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.6.2.5 Canada: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

10.1.6.3 Mexico: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1 Overview

10.1.6.3.2 Mexico: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3 Mexico: Intradermal Injections Market, by Method, 2019–2028 (US$ Million)

10.1.6.3.3.1 Mexico: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.1.6.3.3.2 Mexico: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.1.6.3.4 Mexico: Intradermal Injections Market, by Application, 2019–2028 (US$ Million)

10.1.6.3.5 Mexico: Intradermal Injections Market, by End User, 2019–2028 (US$ Million)

10.2 Europe: Intradermal Injections Market

10.2.1 Overview

10.2.2 Europe: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.3 Europe: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.3.1 Europe: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.3.2 Europe: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.4 Europe: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.5 Europe: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6 Europe: Intradermal Injections Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.1 Overview

10.2.6.1.2 Germany: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3 Germany: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.3.1 Germany: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.6.1.3.2 Germany: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.6.1.4 Germany: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.1.5 Germany: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2 France: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.1 Overview

10.2.6.2.2 France: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3 France: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.3.1 France: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.6.2.3.2 France: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.6.2.4 France: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.2.5 France: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3 UK: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.1 Overview

10.2.6.3.2 UK: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3 UK: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.3.1 UK: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.6.3.3.2 UK: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.6.3.4 UK: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.3.5 UK: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4 Italy: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.1 Overview

10.2.6.4.2 Italy: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3 Italy: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.3.1 Italy: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.6.4.3.2 Italy: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.6.4.4 Italy: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.4.5 Italy: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5 Spain: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.1 Overview

10.2.6.5.2 Spain: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3 Spain: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.3.1 Spain: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.6.5.3.2 Spain: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.6.5.4 Spain: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.5.5 Spain: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6 Rest of Europe: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.1 Overview

10.2.6.6.2 Rest of Europe: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3 Rest of Europe: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.3.1 Rest of Europe: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.2.6.6.3.2 Rest of Europe: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.2.6.6.4 Rest of Europe: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.2.6.6.5 Rest of Europe: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3 Asia Pacific Intradermal Injections Market Revenue and Forecasts To 2028

10.3.1 Overview

10.3.2 Asia Pacific Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.3 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.3.1 Asia Pacific: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.3.2 Asia Pacific: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.4 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.5 Asia Pacific: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3.6 Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)

10.3.6.1 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.1 Overview

10.3.6.1.2 Japan: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.1.3 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.6.1.3.1 Japan: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.6.1.3.2 Japan: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.6.1.4 Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.1.5 Japan: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.1 Overview

10.3.6.2.2 China: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.2.3 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.6.2.3.1 China: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.6.2.3.2 China: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.6.2.4 China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.2.5 China: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.3 India Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.1 Overview

10.3.6.3.2 India: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.3.3 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.6.3.3.1 India: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.6.3.3.2 India: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.6.3.4 India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.3.5 India: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.1 Overview

10.3.6.4.2 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.4.3 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.6.4.3.1 South Korea: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.6.4.3.2 South Korea: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.6.4.4 South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.4.5 South Korea: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.5 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.1 Overview

10.3.6.5.2 Australia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.3.6.5.3 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.6.5.3.1 Australia: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.6.5.3.2 Australia: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.6.5.4 Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.5.5 Australia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6 Rest of Asia Pacific: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.1 Overview

10.3.6.6.2 Rest of Asia Pacific: Intradermal Injections Market – Revenue and Forecast to 2028 (US$ Million)

10.3.6.6.3 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.3.6.6.3.1 Rest of Asia Pacific: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.3.6.6.3.2 Rest of Asia Pacific: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.3.6.6.4 Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.3.6.6.5 Rest of Asia Pacific: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4 Middle East & Africa Intradermal Injections Market Revenue and Forecasts To 2028

10.4.1 Overview

10.4.2 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.3 Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.4.3.1 Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.4.3.2 Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.4.4 Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.4.5 Middle East & Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6 Middle East & Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)

10.4.6.1 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.1 Overview

10.4.6.1.2 UAE: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.1.3 UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.4.6.1.3.1 UAE: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.4.6.1.3.2 UAE: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.4.6.1.4 UAE: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.1.5 UAE: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.1 Overview

10.4.6.2.2 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.2.3 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.4.6.2.3.1 Saudi Arabia: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.4.6.2.3.2 Saudi Arabia: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.4.6.2.4 Saudi Arabia: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.2.5 Saudi Arabia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.1 Overview

10.4.6.3.2 South Africa Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.3.3 South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.4.6.3.3.1 South Africa: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.4.6.3.3.2 South Africa: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.4.6.3.4 South Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.3.5 South Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.4.6.4 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.1 Overview

10.4.6.4.2 Rest of Middle East and Africa: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.4.6.4.3 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.4.6.4.3.1 Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.4.6.4.3.2 Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.4.6.4.4 Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.4.6.4.5 Rest of Middle East and Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5 South And Central America Intradermal Injections Market Revenue and Forecasts To 2028

10.5.1 Overview

10.5.2 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.5.3 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.5.3.1 South and Central America: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.5.3.2 South and Central America: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.5.4 South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.5.5 South and Central America: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6 South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Country (%)

10.5.6.1 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.1.1 Overview

10.5.6.1.2 Argentina Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.1.3 Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.5.6.1.3.1 Argentina: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.5.6.1.3.2 Argentina: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.5.6.1.4 Argentina: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.1.5 Argentina: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.2.1 Overview

10.5.6.2.2 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028 (US$ Million)

10.5.6.2.3 Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.5.6.2.3.1 Brazil: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.5.6.2.3.2 Brazil: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.5.6.2.4 Brazil: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.2.5 Brazil: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

10.5.6.3 Rest of South and Central America: Intradermal Injections Market– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.1 Overview

10.5.6.3.2 Rest of South and Central America: Intradermal Injections Market– Revenue and Forecast to 2028 (US$ Million)

10.5.6.3.3 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

10.5.6.3.3.1 Rest of South & Central America: Intradermal Injections Market, by Short Needles, 2019–2028 (US$ Million)

10.5.6.3.3.2 Rest of South & Central America: Intradermal Injections Market, by Without Needles, 2019–2028 (US$ Million)

10.5.6.3.4 Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts To 2028, By Application (US$ Million)

10.5.6.3.5 Rest of South and Central America: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic On Intradermal Injections Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Intradermal Injections Market–Industry Landscape

12.1 Overview

12.2 Developments

12.2.1 Overview

13. Company Profiles

13.1 BD

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 West Pharmaceutical Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Terumo Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 NanoPass

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Pharmajet

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Idevax

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 EUNSUNG GLOBAL

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Crossject

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Cardinal Health Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Hindustan Syringes and Medical Devices Ltd

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. North America Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Intradermal Injections Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 6. US Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 7. US: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 8. US: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 10. US Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 21. Europe: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 22. Europe: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 23. Europe: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 24. Europe: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 26. Germany: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 27. Germany: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 28. Germany: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 29. Germany: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 30. Germany: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. France: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 32. France: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 33. France: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 34. France: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 35. France: Intradermal Injections Market

Table 36. France: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37. UK: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 38. UK: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 39. UK: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 40. UK: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 41. UK: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 42. Italy: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 43. Italy: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 44. Italy: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 45. Italy: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 46. Italy: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 47. Spain: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 48. Spain: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 49. Spain: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 50. Spain: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 51. Spain: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 52. Rest of Europe: Intradermal Injections Market, by Method – Revenue and Forecast to 2028 (US$ Million)

Table 53. Rest of Europe: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 54. Rest of Europe: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 55. Rest of Europe: Intradermal Injections Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 56. Rest of Europe: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 57. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million).

Table 58. Asia Pacific: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 59. Asia Pacific: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 60. Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 61. Asia Pacific: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 62. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 63. Japan: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 64. Japan: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 65. Japan: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 66. Japan: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 67. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 68. China: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 69. China: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 70. China: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 71. China: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 72. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 73. India: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 74. India: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 75. India: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 76. India: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 77. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 78. South Korea: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 79. South Korea: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 80. South Korea: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 81. South Korea: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 82. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 83. Australia: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 84. Australia: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 85. Australia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 86. Australia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 87. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 88. Rest of Asia Pacific: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 89. Rest of Asia Pacific: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 90. Rest of Asia Pacific: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 91. Rest of Asia Pacific: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 92. Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 93. Middle East & Africa: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 94. Middle East & Africa: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 95. Middle East & Africa: Intradermal Injection Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 96. Middle East & Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 97. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 98. UAE: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 99. UAE: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 100. UAE: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 101. UAE: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 102. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 103. Saudi Arabia: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 104. Saudi Arabia: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 105. Saudi Arabia: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 106. Saudi Arabia: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 107. South Africa Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 108. South Africa: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 109. South Africa: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 110. South Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 111. South Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 112. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 113. Rest of Middle East & Africa: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 114. Rest of Middle East & Africa: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 115. Rest of Middle East & Africa: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 116. Rest of Middle East and Africa: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 117. South and Central America Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 118. South and Central America: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 119. South and Central America: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 120. South and Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 121. South and Central America: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 122. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 123. Argentina: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 124. Argentina: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 125. Argentina: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 126. Argentina: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 127. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 128. Brazil: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 129. Brazil: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 130. Brazil: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 131. Brazil: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 132. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 133. Rest of South & Central America: Intradermal Injections Market, by Short Needles – Revenue and Forecast to 2028 (US$ Million)

Table 134. Rest of South & Central America: Intradermal Injections Market, by Without Needles – Revenue and Forecast to 2028 (US$ Million)

Table 135. Rest of South & Central America: Intradermal Injections Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 136. Rest of South and Central America: Intradermal Injections Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 137. Developments Done by Companies

Table 138. Glossary of Terms

The List of Companies - Intradermal injection Market

1. BD

2. West Pharmaceuticals Services

3. Terumo Corporation

4. Nanopass

5. Pharmajet

6. Idevax

7. Ensung Global

8. Crossject

9. Cardinal Health

10. Hindustan Syringes and Medical Devices

Reason To Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Intradermal Injection market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global Intradermal Injection market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distributions.

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Intradermal injection Market Forecast to 2028 )
  • Single User Price $4,550$3,640
  • Site Price $6,550$5,240
  • Enterprise Price $8,550$6,840
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry